← Leaderboards
Mark Lewis
Bioqual, Inc.
$23,081,773
Attributed
$23,081,773
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.4M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,081,773 · 5
By mechanism
N01$23,023,707 · 5
N02$58,066 · 1
Top collaborators
No co-investigators on record.
Most similar at Bioqual, Inc.
Same institution · by research overlap
- Deborah Weiss$695,753
- Hanne Andersen$3,809,803
- Hanne Elyard$5,288,850
Others in their field
Top investigators on “Nonhuman Primate”
- Dennis R. Burton · Scripps Research Institute$260,759,454
- Lawrence Corey · Fred Hutchinson Cancer Center$225,398,394
- David Heimbrook · Leidos Biomedical Research, Inc.$199,989,000
- Dan H. Barouch · Fred Hutchinson Cancer Center$117,286,351
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$100,712,139
- Peter B. Gilbert · Fred Hutchinson Cancer Center$97,741,049
Research focus
Nonhuman PrimateVaccine EvaluationNational Institute Of Allergy And Infectious DiseaseModalityAids VaccinesVaccinesPreclinical EvaluationResearch PersonnelResourcesVaccine ResearchPrevention StrategyHiv VaccineProgramsPreclinical StudyContractsMaintenancePreventionAdvanced DevelopmentFundingComplementEvaluation StudiesAwardLocal MicrobicidesPre-Clinical
Grant awards (55)
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support$451,691
N01 · FY2025 · AI · contact PI
Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates$209,558
N01 · FY2025 · AI · contact PI
Optimization of SOSIP Nanoparticle and mRNA Immunogens to Elicit V3 Glycan bNAbs in Rhesus Macaques$849,354
N01 · FY2024 · AI · contact PI
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support$439,740
N01 · FY2024 · AI · contact PI
Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates$204,920
N01 · FY2024 · AI · contact PI
Simian Vaccine Evaluation Unit (SVEU) - Core Activities$145,582
N01 · FY2024 · AI · contact PI
Study to investigate the immunogenicity and efficacy of a rVSV-HIVenv Prime, HIV envelope protein boost vaccination regimen and DNA-HIV Prime, rVSV-HIVenv boost vaccination regimen$11,105
N01 · FY2024 · AI · contact PI
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support$427,831
N01 · FY2023 · AI · contact PI
Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates$200,283
N01 · FY2023 · AI · contact PI
Optimization of SOSIP Nanoparticle and mRNA Immunogens to Elicit V3 Glycan bNAbs in Rhesus Macaques$157,696
N01 · FY2023 · AI · contact PI
Simian Vaccine Evaluation Unit (SVEU) - Maintenance of Nonhuman Primates$7,315
N01 · FY2023 · AI · contact PI
Efficacy of Conserved Element SIV Gag Vaccine in Control of SIVmac239 Viremia$408
N01 · FY2023 · AI · contact PI
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support$415,980
N01 · FY2022 · AI · contact PI
Simian Vaccine Evaluation Unit (SVEU) - Core Activities$375,872
N01 · FY2022 · AI · contact PI
Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates$195,656
N01 · FY2022 · AI · contact PI
Optimization of SOSIP Nanoparticle and mRNA Immunogens to Elicit V3 Glycan bNAbs in Rhesus Macaques$530,959
N01 · FY2021 · AI · contact PI
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support$404,141
N01 · FY2021 · AI · contact PI
Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates$191,076
N01 · FY2021 · AI · contact PI
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support$393,447
N01 · FY2020 · AI · contact PI
Simian Vaccine Evaluation Unit: Maintenance of Nonhuman Primates$186,447
N01 · FY2020 · AI · contact PI
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT$673,851
N01 · FY2019 · AI · contact PI
SVEU - Maintenance of Nonhuman Primates$266,873
N01 · FY2019 · AI · contact PI
SVEU - Maintenance of Nonhuman Primates$149,742
N01 · FY2019 · AI · contact PI
Study to investigate the immunogenicity and efficacy of a rVSV-HIVenv Prime, HIV envelope protein boost vaccination regimen and DNA-HIV Prime, rVSV-HIVenv boost vaccination regimen$80,534
N01 · FY2019 · AI · contact PI
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT$653,017
N01 · FY2018 · AI · contact PI
SVEU - Maintenance of Nonhuman Primates$261,258
N01 · FY2018 · AI · contact PI
SVEU - Operation and Maintenance of a Breeding Colony$1,679
N01 · FY2018 · AI · contact PI
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT$632,260
N01 · FY2017 · AI · contact PI
Study to investigate the immunogenicity and efficacy of a rVSV-HIVenv Prime, HIV envelope protein boost vaccination regimen and DNA-HIV Prime, rVSV-HIVenv boost vaccination regimen$465,058
N01 · FY2017 · AI · contact PI
SVEU - Maintenance of Nonhuman Primates$255,699
N01 · FY2017 · AI · contact PI
IGF::OT::IGF SIMIAN VACCINE EVALUATION UNITS$1,624,996
N01 · FY2016 · AI · contact PI
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT$611,569
N01 · FY2016 · AI · contact PI
SVEU - Maintenance of Nonhuman Primates$250,136
N01 · FY2016 · AI · contact PI
Efficacy of Conserved Element SIV Gag Vaccine in Control of SIVmac239 Viremia$53,067
N01 · FY2016 · AI · contact PI
Simian Vaccine Evaluation Units$23,204
N01 · FY2016 · AI · contact PI
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT$590,969
N01 · FY2015 · AI · contact PI
SVEU - Maintenance of Nonhuman Primates$342,398
N01 · FY2015 · AI · contact PI
SVEU - MAINTENANCE OF NONHUMAN PRIMATES$260,807
N01 · FY2015 · AI · contact PI
Conduct Study P189$115,753
N01 · FY2015 · AI · contact PI
EFFIVAVY OF CONSERVED ELEMENT SIV GAG VACCINCE IN CONTROL OF SIVmac239 VIREMIA$77,788
N01 · FY2015 · AI · contact PI
SVEU - IMMUNOGENICITY OF A NONINTEGRATING INTEGRASE-DEFECTIVE LENTIVIRAL VECTOR$61,940
N01 · FY2015 · AI · contact PI
IN VIVO SHIV TITRATION VIA INTRATECTAL ROUTE IN INDIAN-ORIGIN RHESUS MACAQUES$39,631
N01 · FY2015 · AI · contact PI
EFFIVAVY OF CONSERVED ELEMENT SIV GAG VACCINCE IN CONTROL OF SIVmac239 VIREMIA$610,218
N01 · FY2014 · AI · contact PI
SVEU - CORE ACTIVITIES: ADMINISTRATIVE AND TECHNICAL SUPPORT$570,443
N01 · FY2014 · AI · contact PI
SVEU - Maintenance of Nonhuman Primates$237,885
N01 · FY2014 · AI · contact PI
IN VIVO SHIV TITRATION VIA INTRATECTAL ROUTE IN INDIAN-ORIGIN RHESUS MACAQUES$154,229
N01 · FY2014 · AI · contact PI
SVEU - Evaluation of Prime-Boost Regimen Emplyoing Clade C Proteins$121,834
N01 · FY2014 · AI · contact PI
Task B16: Comprehensive Virology Panel$58,066
N02 · FY2014 · AI · contact PI
Simian Vaccine Evaluation Units$2,435,221
N01 · FY2012 · AI · contact PI
Simian Vaccine Evaluation Units$2,300,238
N01 · FY2011 · AI · contact PI
Task C11: NHP Model for Filovirus Vaccines$656,155
N01 · FY2011 · AI · contact PI
Task C05: Testing a Multivalent Lymphatic Filiariasis Vaccine in Rhesus Monkeys$369,242
N01 · FY2011 · AI · contact PI
Task B01: In Vitro Assessments for Viral Diseases$32,941
N01 · FY2011 · AI · contact PI
Task B01: In Vitro Assessments for Viral Diseases$9,323
N01 · FY2011 · AI · contact PI
Simian Vaccine Evaluation Units$2,234,688
N01 · FY2010 · AI · contact PI